Abstract Tumor necrosis factor receptor-associated periodic syndrome (TRAPS), an autosomal disease belonging to human autoinflammatory syndromes, is caused by mutations in Tumor Necrosis Factor Receptor Superfamily Member 1A (TNFRSF1A) gene. Trübenbach and colleagues described a patient with two heterozygotic nucleotide transversions in exon 4 of TNFRSF1A gene: the first is a substitution from guanine to cytosine at position 263 of the nucleotide sequence (c.263 G[C); the second is a substitution from cytosine to adenine at position 264 (c.264 C[A); the two mutations affect the amino acid number 88 of the protein. To date, this was the first report of a double monoallelic mutation in a gene related to autoinflammatory syndromes. Using two web interfaces (ESEfinder and RESCUE-ESE), we provide evidence that the double nucleotide change may affect an exonic splicing enhancer (ESE), a sequence element distinct from the canonical splice sites that are needed for normal splicing. ESEs are short and degenerate sequences found within coding exons and required for efficient splicing and splice site recognition. In order to verify if these changes really affect an ESE, it would be useful to analyze the described index case TNFRSF1A cDNA, because if this analysis will evidence an exon skipping in the TNFRSF1A coding sequence, it would then represent the first mutation in autoinflammatory syndromes demonstrated to be caused by ESE elements alteration.
Keywords Hereditary periodic fever syndromes (HPFSs) Á Autoinflammatory syndromes Á TNF receptorassociated periodic fever syndrome (TRAPS) Á Exonic splicing enhancers (ESEs) Á ESEfinder Á RESCUE-ESE Dear Editor, We read with great interest the article by Trübenbach and colleagues reporting a patient affected by a hereditary periodic fever syndrome (HPFS), a disease belonging to human autoinflammatory syndromes, characterized by periodic fever and inflammation signs with or without involvement of inner organs [1] . Primarily, the index case was clinically diagnosed as having Familial Mediterranean Fever (FMF), which is caused by mutations in MEFV gene, but after genetic analysis, two monoallelic Tumor Necrosis Factor Receptor Superfamily Member 1A (TNFRSF1A) gene mutations were revealed. TNFRSF1A is the gene involved in tumor necrosis factor receptor-associated periodic syndrome (TRAPS), a different HPFS with an autosomal dominant Mendelian inheritance (one mutation is sufficient to diagnose the disease).
Trübenbach and colleagues described two nucleotide transversions in exon 4 of TNFRSF1A gene: the first is a substitution from guanine to cytosine at position 263 of the nucleotide sequence (c.263 G[C); the second is a substitution from cytosine to adenine at position 264 (c.264 C[A). Both alterations are in heterozygotic form, and cause a codon variation from cysteine (TGC triplet) to serine (TCA triplet) at amino acid number 88 of the protein. Extending the molecular test to the HPFS affected family members (the father and a paternal cousin of the index case), a monoallelic inheritance mode (in which only one gene copy is affected by both mutations) was concluded (not a compound heterozygosity, in which each gene copy carries a mutation). The authors described this finding as the first report of a double monoallelic mutation in a gene related to HPFS.
Previous studies have indicated that sequence elements, distinct from the canonical splice sites, are also needed for normal splicing (the mechanism of the removal of intron sequences and the consequently link of the exon elements from the premature messenger RNA to the mature mRNA). These sequences are short, degenerate, frequently purinerich sequences found within coding exons and are called exonic splicing enhancers (ESEs); they are required for efficient splicing and may affect splice site recognition during constitutive and alternative splicing [2] .
Most ESEs are predicted to function as binding sites for SR proteins, a family of splicing factors with RNA recognition motifs and Serine/Arginine-rich regions called RS-domains. The RNA binding domain binds to consensus sequences and stabilizes the interaction of splice sites recognition complexes, enhancing exon inclusion and regulating splice site selection [3, 4] .
ESEs have been identified in a large number of genes, and their disruption has been linked to several genetic disorders [5] . In particular, in NF1 gene (the gene responsible of the Neurofibromatosis type 1) has been demonstrated that a dinucleotide heterozygotic variation causes exon skipping. In that paper, as well as in the Trübenbach's paper, the two nucleotides are quite distant from the acceptor, donor splice sites and the consensus sequences.
In order to verify whether the two sequence changes might abrogate or create putative TNFRSF1A exon 4 ESEs, we used two web programs. The first was ESEfinder (http://rulai.cshl.edu/tools/ESE/) interface [6] The combined occurrence of both consecutive nucleotide variations results to abrogate a recognition site for SF2/ ASF SR element (from score 3.14 to 0) at nucleotides 264-270, and a recognition site for SF2/ASF-IgM-BRCA1 SR element (from score 3.21 to 0) at nucleotides 264-270, while it creates a recognition site for SRp40 SR element (from score 0 to 3.20) at nucleotides 260-266 (Fig. 1) . Interestingly, the SC35 recognition site is absent both with the wild-type and the double-variation, but is present with the c.264 C[A change.
The nucleotides 263 and 264 show complete conservation during evolution (100% homology in mouse, human and rat); this data suggest a conserved role of these two RS elements in TNFRSF1a splicing function.
Then we used RESCUE-ESE web interface (http:// genes.mit.edu/burgelab/rescue-ese/), which identifies hexamers candidate for ESEs, using a large database of human genes of known exon-intron structure containing over 30,000 redundant exons [7] . Testing singularly the two nucleotide variations, both do not show any ESE element formation, while together create an ESE element from 259 to 264 nucleotides in TNFRSF1A gene ( Table 1) .
The two web tools used can have some problems: not all sequences demonstrated to show ESE activity are SR protein binding motifs; this fact may cause the underecognition of true ESE elements using in silico interfaces. Furthermore, both ESEfinder and RESCUE-ESE have been shown to have a high rate of false positive and negative results [8, 9] . In general, the correlation between numerical scores generated by in silico tools and in vivo ESE activity is not always satisfied. Direct experimental evidence remains necessary before postulating that a sequence variation affects an ESE motif.
It would be interesting to perform further analysis in order to evidence a possible exon skipping in the index case TNFRSF1A gene described by Trübenbach and colleagues.
The more used approach is to analyze the coding sequence (cDNA) of the index patient trying to evidence potential exon skipping caused by the two nucleotide changes; this test should be performed retro-transcribing the extracted RNA from peripheral blood lymphocytes cultures and treated with puromycin to prevent non-sense mRNA-mediated decay [10] . The TNFRSF1A cDNA should be then divided in overlapping fragments, amplified by PCR, and finally sequenced.
If this analysis will evidence an exon skipping in the TNFRSF1A coding sequence, it would then represent the first mutation in HPFSs demonstrated to be caused by ESE elements alteration. Table 1 Results from analysis with RESCUE-ESE web-interface An ESE element (from nucleotides 259 to 264 in the TNFRSF1A sequence) is created only when both the two nucleotide variations are present, indicating that the combined effect of the two changes may affect the normal splicing
